Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wyeth Normiflo low molecular weight heparin approved by FDA May 23.

Executive Summary

WYETH-AYERST NORMIFLO LOW MOLECULAR WEIGHT HEPARIN CLEARS FDA May 23 for prevention of deep vein thrombosis in knee replacement surgery patients. Normiflo (aldeparin) will be the third low molecular weight heparin on the market. Rhone-Poulenc Rorer markets Lovenox for hip and knee replacement procedures and recently received clearance for use of the product in abdominal surgery ("The Pink Sheet" May 19, T&G-6). Pharmacia & Upjohn markets Fragmin for abdominal surgery and has filed for hip replacement.
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS030274

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel